Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INSULIN DEGLUDEC Cause Neuropathy peripheral? 160 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 160 reports of Neuropathy peripheral have been filed in association with INSULIN DEGLUDEC (TRESIBA). This represents 1.4% of all adverse event reports for INSULIN DEGLUDEC.

160
Reports of Neuropathy peripheral with INSULIN DEGLUDEC
1.4%
of all INSULIN DEGLUDEC reports
0
Deaths
11
Hospitalizations

How Dangerous Is Neuropathy peripheral From INSULIN DEGLUDEC?

Of the 160 reports, 11 (6.9%) required hospitalization, and 1 (0.6%) were considered life-threatening.

Is Neuropathy peripheral Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INSULIN DEGLUDEC. However, 160 reports have been filed with the FAERS database.

What Other Side Effects Does INSULIN DEGLUDEC Cause?

Blood glucose increased (2,644) Blood glucose decreased (983) Hypoglycaemia (762) Nausea (543) Drug ineffective (449) Dyspnoea (390) Vomiting (381) Stress (368) Weight increased (364) Constipation (334)

What Other Drugs Cause Neuropathy peripheral?

LENALIDOMIDE (10,215) BORTEZOMIB (4,067) OXALIPLATIN (3,662) DEXAMETHASONE (3,543) PACLITAXEL (3,508) LEVOFLOXACIN (2,619) CIPROFLOXACIN (2,607) FLUOROURACIL (2,605) CYCLOPHOSPHAMIDE (2,565) POMALIDOMIDE (2,382)

Which INSULIN DEGLUDEC Alternatives Have Lower Neuropathy peripheral Risk?

INSULIN DEGLUDEC vs INSULIN DEGLUDEC\LIRAGLUTIDE INSULIN DEGLUDEC vs INSULIN DETEMIR INSULIN DEGLUDEC vs INSULIN GLARGINE INSULIN DEGLUDEC vs INSULIN GLARGINE-YFGN INSULIN DEGLUDEC vs INSULIN GLARGINE\LIXISENATIDE

Related Pages

INSULIN DEGLUDEC Full Profile All Neuropathy peripheral Reports All Drugs Causing Neuropathy peripheral INSULIN DEGLUDEC Demographics